SEC Stock Data Quick Answer ZJK Industrial Co., Ltd. reported Total Assets of $55.77 million for fiscal year 2024. ZJK Industrial Co., Ltd. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2024 $55.77M +45.7% 2023 $38.28M — ZJK Industrial Co., Ltd. showed an increase of +45.7% in Total Assets compared to the prior fiscal year. … Read more
Quick Answer ZJK Industrial Co., Ltd. reported Diluted EPS of $0.06 per share for fiscal year 2024. ZJK Industrial Co., Ltd. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2024 $0.06 -53.8% 2023 $0.13 +8.3% 2022 $0.12 — ZJK Industrial Co., Ltd. showed a decrease of -53.8% in Diluted EPS compared to … Read more
Quick Answer ZJK Industrial Co., Ltd. reported Total Revenue of $37.81 million for fiscal year 2024. ZJK Industrial Co., Ltd. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2024 $37.81M +30.1% 2023 $29.06M +17.2% 2022 $24.79M — ZJK Industrial Co., Ltd. showed an increase of +30.1% in Total Revenue compared to the … Read more
Quick Answer ZJK Industrial Co., Ltd. reported Total Revenue of $37.81 million for fiscal year 2024. ZJK Industrial Co., Ltd. — Key Financials by Year Metric 2024 2023 2022 2021 Total Revenue $37.81M+30.1% $29.06M+17.2% $24.79M — Diluted EPS $0.06-53.8% $0.13+8.3% $0.12 — Total Assets $55.77M+45.7% $38.28M — — Cash and Equivalents $12.26M+333.5% $2.83M — — … Read more
Quick Answer Zivo Bioscience, Inc. reported Shares Outstanding of 3.62 million shares for fiscal year 2024. Zivo Bioscience, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 3.62M +52.0% 2023 2.38M +51.7% 2022 1.57M -83.3% 2021 9.42M +82.4% 2020 5.16M -98.8% 2019 413.04M +129.4% 2018 180.04M +27.6% 2017 141.11M +3.2% 2016 … Read more
Quick Answer Zivo Bioscience, Inc. reported Gross Profit of $49.0 thousand for fiscal year 2024. Zivo Bioscience, Inc. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2024 $49.0K +321.6% 2023 $11.6K — 2022 $0.00 — Quarterly Gross Profit Quarter Ending Gross Profit YoY QoQ September 30, 2025 $21.3K +125.3% +18.8% June 30, … Read more
Quick Answer Zivo Bioscience, Inc. reported Operating Income of -$13.36 million for fiscal year 2024. Zivo Bioscience, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2024 -$13.36M -84.0% 2023 -$7.26M +16.8% 2022 -$8.73M -1.0% 2021 -$8.65M -1.0% 2020 -$8.56M -2.4% 2019 -$8.35M -36.2% 2018 -$6.13M +3.2% 2017 -$6.33M -81.4% 2016 -$3.49M … Read more
Quick Answer Zivo Bioscience, Inc. reported R&D Expense of $3.13 million for fiscal year 2024. Zivo Bioscience, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $3.13M +127.7% 2023 $1.38M -38.5% 2022 $2.24M +14.9% 2021 $1.95M -48.1% 2020 $3.75M +62.8% 2019 $2.31M -18.0% 2018 $2.81M +18.2% 2017 $2.38M +201.8% 2016 $789.0K … Read more
Quick Answer Zivo Bioscience, Inc. reported Stockholders Equity of -$514.9 thousand for fiscal year 2024. Zivo Bioscience, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2024 -$514.9K +76.7% 2023 -$2.21M -20666.7% 2022 -$10.6K -100.2% 2021 $6.04M +153.4% 2020 -$11.31M -35.6% 2019 -$8.34M +62.6% 2018 -$22.28M -36.7% 2017 -$16.30M -19.7% 2016 -$13.62M … Read more
Quick Answer Zivo Bioscience, Inc. reported Cash and Equivalents of $1.80 million for fiscal year 2022. Zivo Bioscience, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2022 $1.80M -79.8% 2021 $8.90M +6357.1% 2020 $137.9K -60.2% 2019 $346.1K -11.0% 2018 $388.9K +22.6% 2017 $317.1K -37.4% 2016 $507.0K +2956.2% 2015 $16.6K … Read more